The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2022 Summer Meeting | The centralization of molecular testing

Name: The centralization of molecular testing
Uploaded: 2022-07-08T00:00:00Z
Duration: 4 min 4 s
Description: John Gosney, BSc, MBChB, Liverpool University Hospitals NHST, UK, discusses the benefits of centralizing genomic testing. Additionally, the challenges involved in the implementation of molecular testing are reviewed and future directions are discussed. This interview took place at the BTOG 2022 Summer Meeting congress in London.

John Gosney • 8 Jul 2022

BTOG 2022 Summer Meeting

Lung Cancer

John Gosney, BSc, MBChB, Liverpool University Hospitals NHST, UK, discusses the benefits of centralizing genomic testing. Additionally, the challenges involved in the implementation of molecular testing are reviewed and future directions are discussed. This interview took place at the BTOG 2022 Summer Meeting congress in London.